ClinicalTrials.gg
Not yet recruitingNCT07950176Updated Nov 20, 2026

Pilates Exercises for Postpartum Constipation

An interventional study of Pilates Exercise Program and Standard Postpartum Care in Postpartum Constipation, sponsored by Kafrelsheikh University. Not yet recruiting. Open to female participants aged 22 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 20, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
22 Years to 35 Years
Sex
Female
01

Study summary

Postpartum constipation is a common problem that can affect women's comfort and quality of life after childbirth. This study aims to evaluate whether Pilates exercises can help improve constipation symptoms in women after vaginal delivery.

A total of 40 women aged 22-35 years with postpartum constipation will participate in this study. Participants will be randomly assigned to two groups, with 20 women in each group. The first group will receive a supervised Pilates exercise program in addition to standard postpartum care, while the second group will receive standard postpartum care alone.

The Pilates program will last for 9 weeks, with three supervised sessions per week. Standard postpartum care will include advice about healthy eating, adequate fluid intake, dietary fiber, and physical activity.

Constipation symptoms, bowel habits, stool consistency, and constipation-related quality of life will be assessed before and after the intervention. The results of both groups will be compared to evaluate whether adding Pilates exercises to standard postpartum care improves postpartum constipation.

Read the detailed description

Postpartum constipation is a frequent gastrointestinal complaint that may develop or worsen after childbirth. It can be associated with several physiological and lifestyle changes during the postpartum period, including reduced physical activity, changes in dietary habits, hormonal fluctuations, perineal discomfort, and altered pelvic floor muscle function. These factors may contribute to difficult defecation, straining, and impaired bowel habits, potentially affecting women's physical comfort and quality of life.

Pilates is a form of therapeutic exercise that emphasizes controlled movements, breathing coordination, postural alignment, flexibility, and activation of the deep trunk muscles. It may help improve abdominal muscle function, trunk stability, body awareness, and coordination between breathing and movement. These components may be relevant to bowel function and pelvic floor muscle coordination.

Although physical activity and exercise are commonly recommended as part of conservative management for constipation, the effectiveness of a structured Pilates exercise program specifically for postpartum constipation requires further investigation.

This study is designed to investigate the potential benefits of incorporating Pilates exercises into standard postpartum care for women experiencing constipation after vaginal delivery.

The exercise program will be supervised by a physiotherapist and progressively adapted according to the participants' abilities and tolerance. Exercises will emphasize controlled breathing, coordinated movement, and appropriate activation of the trunk muscles without excessive straining or breath-holding.

The study aims to provide evidence regarding the role of Pilates exercises as a non-pharmacological complementary approach to the management of postpartum constipation and to explore their potential contribution to improving bowel function and constipation-related quality of life.

02

Conditions studied

  • Postpartum Constipation

Browse trials for

03

In context

Constipation

1,051 studies on the registry are indexed under Constipation; 163 are open to participants now.

This study's planned enrollment of 40 is below the median of 75 across 889 interventional studies indexed under Constipation.

Browse Constipation studies →

Lead sponsor

Kafrelsheikh University is the lead sponsor of 305 studies on the registry; 122 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- 1. Women aged 22-35 years. 2. Primiparous women (first childbirth). 3. History of vaginal delivery. 4. 2-6 weeks postpartum at the time of enrollment. 5. Presence of functional constipation according to Rome IV diagnostic criteria.

6. (BMI) between 30 and 32 kg/m². 7. Ability and willingness to participate in the 9-week exercise program. 8. Provision of .

Exclusion criteria

Exclusion Criteria:

- 1. Women with hypertension 2. Women with cardiac diseases. 3. Women with diabetes mellitus. 4. Women with a history of inflammatory bowel disease, abnormalities, or anal fissures.

5. Women with a history of bowel surgery, except appendectomy. 6. Women with endocrine or gastrointestinal disorders. 7. Women with neurological or muscular disorders.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Pilates Exercise Group

    Participants in this group will receive a supervised Pilates exercise program in addition to standard postpartum care. The program will be conducted three times per week for 9 weeks, with each session lasting approximately 40-45 minutes. Exercises will be progressively adjusted according to participants' abilities and tolerance.

    Behavioral: Pilates Exercise Program · Other: Standard Postpartum Care

  • Active comparator
    Standard Postpartum Care Group

    Participants in this group will receive standard postpartum care alone, including advice on healthy eating, adequate fluid intake, dietary fiber, and physical activity, without the addition of a structured Pilates exercise program.

    Other: Standard Postpartum Care

Interventions

  • BehavioralPilates Exercise Program

    A supervised Pilates exercise program designed for women with postpartum constipation. The program will be conducted for 9 weeks, with three sessions per week. Each session will last approximately 40-45 minutes. Exercises will focus on controlled breathing, coordinated movement, postural alignment, and activation of the deep trunk muscles. The exercise intensity and progression will be adjusted gradually according to participants' abilities and tolerance. Participants will be instructed to maintain normal breathing and avoid breath-holding or excessive straining during exercise.

  • OtherStandard Postpartum Care

    Standard postpartum care consisting of advice on healthy dietary habits, adequate fluid intake, appropriate dietary fiber consumption, and regular physical activity, including walking for 30-45 minutes three times per week.

06

What researchers measure

Primary outcomes

  1. Change in Patient Assessment of Constipation Symptoms (PAC-SYM) Total Score

    The severity of constipation symptoms will be assessed using the 12-item Patient Assessment of Constipation Symptoms (PAC-SYM) questionnaire. The total score will be used to evaluate changes in constipation symptom severity, with higher scores indicating more severe symptoms.

    Time frame: Baseline to 9 weeks after the intervention

  2. Change in Patient Assessment of Constipation Quality of Life (PAC-QOL) Total Score

    Constipation-related quality of life will be assessed using the 28-item Patient Assessment of Constipation Quality of Life (PAC-QOL) questionnaire. The questionnaire evaluates physical discomfort, psychosocial discomfort, worries and concerns, and satisfaction. Higher scores indicate greater impairment in quality of life.

    Time frame: Baseline to 9 weeks after the intervention

Secondary outcomes

  1. Change in Stool Consistency According to the Bristol Stool Form Scale

    Stool consistency will be assessed using the Bristol Stool Form Scale (BSFS), which classifies stool into seven types according to its shape and consistency. Changes in stool form will be evaluated between baseline and post-intervention assessment.

    Time frame: Baseline to 9 weeks after the intervention

  2. Change in Pelvic Floor Muscle Strength Measured by Validated Perineometer

    Pelvic floor muscle strength will be assessed using a calibrated perineometer. The mean pressure recorded during three maximal voluntary contractions will be used to evaluate changes in pelvic floor muscle strength. Measurements will be expressed in cmH₂O.

    Time frame: Baseline to 9 weeks after the intervention

  3. Change in Abdominal Circumference

    Abdominal circumference will be measured using a non-elastic measuring tape at a standardized anatomical site. Measurements will be taken in centimeters under standardized conditions to assess changes in abdominal circumference following the intervention.

    Time frame: Baseline to 9 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for May 2027, 6 months later.

Of 246 non-industry interventional studies with no phase under Constipation, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 35. This study's planned 6 months is below that.

Counting every sponsor, half of 317 studies reached it within 14 months; a quarter within 6 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2026
First posted
Nov 20, 2026
StartEst.
Nov 10, 2026
Primary completionEst.
May 10, 2027
CompletionEst.
Jun 10, 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07950176
Responsible party
Rania Hassan Hassan (Rania Hassan, Kafrelsheikh University) — Principal investigator
First posted
Nov 20, 2026
Start date
Nov 10, 2026 (estimated)
Primary completion
May 10, 2027 (estimated)
Completion
Jun 10, 2027 (estimated)
Last update
Nov 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion